US

Science is seeking $100 mln third venture fund

Science Inc, a Santa Monica, California-based venture firm and incubator, is raising its third $100 million venture fund, according to a filing with the SEC.

Obvious Ventures raises $154.3 mln toward venture-capital fund

Obvious Ventures has raised $154.3 million toward a third venture-capital fund, according to a filing with the SEC.

Revolution to raise $150 mln second Rise of the Rest seed fund

Revolution has set out to raise a $150 million second Rise of the Rest seed fund, according to a filing with the SEC.

Play Ventures collects $40 mln for debut fund

Play Ventures has raised $40 million for its inaugural fund, according to an SEC filing. The Singapore-based venture firm invests in gaming startups.

Origin Ventures promotes two to VP and another to platform director

Origin Ventures has promoted Scott Stern and Prashant Shukla to vice president, according to a company announcement. Also, the firm has upped Devon Leichtman to director of platform. Stern first joined Origin Ventures in 2016 while Shukla came on board in 2017. Leichtman also joined the firm in 2017.

Microsoft buys VC-backed BlueTalon

Microsoft has acquired BlueTalon, a provider of unified data access control solutions for modern data platforms, according to a blog post on the Microsoft site. No financial terms were disclosed. BlueTalon's backers included Maverick Ventures, Arsenal Venture Partners, Signia Venture Partners, Data Collective, Divergent Ventures, Bloomberg Beta and Stanford-StartX Fund.

DataGrail pockets $5 mln

DataGrail, a privacy management platform, has raised $5 million in funding, according to a blog post on its site. Cloud Apps Capital Partners led the round.

PredictImmune attracts Series B

UK-based PredictImmune, a developer of prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, has closed its Series B funding round at 10 million pounds. The investors included Parkwalk, Cambridge Enterprise and BGF.

Quanta Dialysis Technologies pulls in $48 mln

UK-based Quanta Dialysis Technologies Ltd, a developer of a personal haemodialysis system for patient use in the clinic and the home, has raised $48 million in funding. The investors included btov Partners, Wellington Partners and Seroba Life Sciences.

DCM leads $5 mln round for DocSend

DCM is leading a $5 million funding round for DocSend, a document sharing and tracking platform, according to a blog post by DCM Partner Kyle Lui. In addition to the funding, Lui will join DocSend's board of directors.